SAN FRANCISCO, Calif-Stanford University researchers are attempting to alter E. coli<$> bacteria in an effort to create erythromyacin-one of the most powerful antibiotics being used today.
They are altering the bacteria genetically to create the antibiotic because current methods of producing the drug are time-consuming. This specific bacterium was chosen because it grows rapidly. Altering its genetic foundation would give researchers a faster and less expensive method of creating mass amounts of the antibiotic.
By genetically altering the germ, scientists could also stay one step ahead of the ever-evolving world of germs. Each time a germ adapts to work around current antibacterial technology, scientists could in turn alter their mutation to their manufactured antibiotic.
A different ironic twist in the world of genetically altered treatments is developing with tobacco research. A different group of scientists is trying to alter the genetics of the leafy plant to create a new array of medicines to fight everything from cancer to tooth decay.
They estimate this group of drugs will be developed and a dominant aspect of US pharmacology within 10 years.
Information from www.sfgate.com
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
Blood Product Overtransfusion Is a Global Issue: Here Are 5 Reasons the Practice Must Change
October 9th 2024If a patient receives treatment or therapy that they do not need, it can cause unnecessary harm. This is true for medications, surgeries, and medical procedures, especially blood transfusions.